NR1H4 and metabolic dysfunction-associated steatotic liver disease: While bile acids, through FXR and GPBAR1 signaling, can inhibit liver fat accumulation and inflammation, alterations in the bile acid pool and gut microbiota can also contribute to MASLD pathogenesis.